Skip to Main Content
Hospital Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: As we launch new branding in the coming months, you will see updates to the logos. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Insulin

Insulin

  • Diabetes (380)
    • Blood Glucose Meters (3)
    • Complications (133)
    • Diabetes in Pregnancy (6)
    • Diabetes Meds (66)
    • Drug-Induced Hypo/Hyperglycemia (112)
    • Monitoring (77)
    • Natural Medicines/Supplements (4)
    • Prevention (26)
    • Treatment (228)
      • Alpha-Glucosidase Inhibitors (19)
      • Amylin Agonist (12)
      • Bromocriptine (7)
      • Combination Products (10)
      • Gliptins (59)
      • Glitazones (85)
      • GLP-1 (33)
      • Incretin Enhancers/Mimetics (50)
      • Insulin (122)
      • Meglitinides (32)
      • Metformin (99)
      • SGLT2 Inhibitors (71)
      • Sulfonylureas (81)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (10)
  • Hyperglycemia (35)
  • Hypoglycemia (20)
  • Other (16)
  • Prediabetes (1)
  • Resources (172)
  • Thyroid Disorders (24)
61 - 75 of 122 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: The New U-500 Syringe Will Eliminate the Need for Dose Conversions November 2016
Algorithm: Management of New-Onset Type 2 Diabetes October 2016
Article: Avoid Restarting Risky Meds at Discharge in Heart Failure Patients September 2016
PL Voices: Meds to Avoid in Heart Failure Patients September 2016
Chart: Medications and Supplements With Adverse Effects in Heart Failure September 2016
Commentary: Have Meds Will Travel July 2016
Article: Check For Duplicate Insulins on Discharge Orders July 2016
Article: Stop Saxagliptin or Alogliptin in Patients Who Develop Heart Failure June 2016
Commentary: DPP-4 Inhibitors (Gliptins) and Risk of Heart Failure June 2016
Other: Pharmacologic Management of Type 2 Diabetes: 2016 Interim Update June 2016
Patient Education: Travel and Your Medicines June 2016
Article: Don't Stop Basal Insulins When Patients are NPO May 2016
Patient Education: Diabetes and Fasting May 2016
Article: Create Insulin Pump Protocols for Your Hospital April 2016
Article: Choose the U-500 Kwikpen Over U-500 Vials April 2016
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved